最初
发表于 2025-3-27 00:12:12
http://reply.papertrans.cn/17/1642/164131/164131_31.png
死亡
发表于 2025-3-27 04:44:12
http://reply.papertrans.cn/17/1642/164131/164131_32.png
使坚硬
发表于 2025-3-27 08:54:33
Gabriele Hooffacker,Robert Kohlickhave a crucial role in characterizing disease, the testing activity of novel therapies, and proper evaluation of therapeutic efficacy. Traditionally, treatment response evaluation in oncology is based on comparing the size or volume of the tumor before and after treatment. The introduction of molecu
florid
发表于 2025-3-27 11:13:38
http://reply.papertrans.cn/17/1642/164131/164131_34.png
新星
发表于 2025-3-27 16:50:34
http://reply.papertrans.cn/17/1642/164131/164131_35.png
labyrinth
发表于 2025-3-27 21:39:28
http://reply.papertrans.cn/17/1642/164131/164131_36.png
卵石
发表于 2025-3-27 23:40:36
http://reply.papertrans.cn/17/1642/164131/164131_37.png
hazard
发表于 2025-3-28 02:43:18
http://reply.papertrans.cn/17/1642/164131/164131_38.png
责问
发表于 2025-3-28 06:43:29
Jean-François Mertens,Sylvain Sorint of disease, such as CT evaluation using the Response Evaluation Criteria in Solid Tumors (RECIST). However, such measurements are of limited value following radiotherapy. The challenge of determining the presence or absence of viable tumor within residual masses following radiotherapy provides a c
ESO
发表于 2025-3-28 14:23:40
http://reply.papertrans.cn/17/1642/164131/164131_40.png